DAY 1
DAY 2
DAY 3
Skip Navigation
Skip to contents
Adult Congenital Heart Disease 2
PAH with Common Shunts
Se Yong Jung, MD, PhD
Yonsei University, Korea
How to use Antithrombotic Agent in Patientst with Heart Disease and Cancer Treatment- Cardiologist View
Treatment Option for Atrial Functional MR
Catheter Ablation of Atrial Fibrillation in Patient with Hypertrophic Cardiomyopathy
Pulsed Field Ablation: Higher Success Rates with Less Complication?
Roles of Programed electrical Stimulation Test in Channelopathies
Lessons from DanGer-Shock and ECLS-Shock Trials
Lessons from Recent RCTs Regarding ECPR
GLP1-RA in Cardiology: Beyond Diabetes and Obesity Control
Glycemic Control in 2024: Latest Guidelines and Optimal Strategies
From “Emerging Field” to “Global Trend” : Cardio-Oncology in Japan
Management of Disease, from the Old to New Treatments
Preventive PCI for Functionally Insignificant Vulnerable Plaque: PREVENT Trial
SGLT2 Inhibitors in AMI: DAPA MI VS. EMPACT MI
Sex-related Factors in Valvular Heart Disease
CLOSE
